Kathryn E.K.E.WebertKathryn E.K.E., Acquired hemophilia A, „Seminars in Thrombosis and Hemostasis”, 38 (7), 2012, s. 735–741, DOI: 10.1055/s-0032-1326779, ISSN1098-9064, PMID: 22941793 [dostęp 2018-07-10].
doi.org
M. Senthil, P. Chaudhary, DD. Smith, PE. Ventura i inni. A shortened activated partial thromboplastin time predicts the risk of catheter-associated venous thrombosis in cancer patients.. „Thromb Res”. 134 (1), s. 165–168, Jul 2014. DOI: 10.1016/j.thromres.2014.04.022. PMID: 24830901.
nih.gov
ncbi.nlm.nih.gov
G. Lippi, GL. Salvagno, L. Ippolito, M. Franchini i inni. Shortened activated partial thromboplastin time: causes and management.. „Blood Coagul Fibrinolysis”. 21 (5), s. 459–463, Jul 2010. PMID: 20614573.
Kathryn E.K.E.WebertKathryn E.K.E., Acquired hemophilia A, „Seminars in Thrombosis and Hemostasis”, 38 (7), 2012, s. 735–741, DOI: 10.1055/s-0032-1326779, ISSN1098-9064, PMID: 22941793 [dostęp 2018-07-10].
M. Senthil, P. Chaudhary, DD. Smith, PE. Ventura i inni. A shortened activated partial thromboplastin time predicts the risk of catheter-associated venous thrombosis in cancer patients.. „Thromb Res”. 134 (1), s. 165–168, Jul 2014. DOI: 10.1016/j.thromres.2014.04.022. PMID: 24830901.
worldcat.org
Kathryn E.K.E.WebertKathryn E.K.E., Acquired hemophilia A, „Seminars in Thrombosis and Hemostasis”, 38 (7), 2012, s. 735–741, DOI: 10.1055/s-0032-1326779, ISSN1098-9064, PMID: 22941793 [dostęp 2018-07-10].